MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, ...
CoreLogic®, a leading global property information, analytics and data-enabled solutions provider, today released the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback